Depleting effect of antithymocyte globulin on T-lymphocyte subsets in kidney transplantation.
Mestre
M
M
Service of Immunology, CSU de Bellvitge, Barcelona, Spain.
Bas
J
J
Alsina
J
J
Grinyó
J M
JM
Buendia
E
E
D015703:Antigens, CD / Q000097:blood; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008212:Lymphocyte Depletion; D015166:Monitoring, Immunologic; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011184:Postoperative Period; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D013997:Time Factors
D015703:Antigens, CD; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine